Jean-Marie Eveillard - First Eagle Investment Management,
Holding/activity history for D Enzon Pharmaceuticals Inc (EZ1)
| Period | Shares | % of Portfolio | Activity | % Change to Portfolio | Reported Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| 2012 Q4 | 0 | 0.00 | Sell 100.00% | 0.02 | SEC | ||
| 2012 Q3 | 490,142 | 0.02 | Reduce 56.42% | 0.02 | $6.96 | $3,411,000 | SEC |
| 2012 Q2 | 1,124,580 | 0.04 | Reduce 4.88% | <0.01 | $6.87 | $7,726,000 | SEC |
| 2012 Q1 | 1,182,252 | 0.04 | Reduce 2.57% | <0.01 | $6.84 | $8,087,000 | SEC |
| 2011 Q4 | 1,213,387 | 0.05 | $6.70 | $8,130,000 | SEC | ||
| 2011 Q3 | 1,213,387 | 0.06 | $7.04 | $8,542,000 | SEC | ||
| 2011 Q2 | 1,213,387 | 0.08 | $10.05 | $12,195,000 | SEC | ||
| 2011 Q1 | 1,213,387 | 0.09 | $10.90 | $13,226,000 | SEC | ||
| 2010 Q4 | 1,213,387 | 0.05 | $12.17 | $14,767,000 | SEC | ||
| 2010 Q3 | 1,213,387 | 0.12 | $11.25 | $13,651,000 | SEC | ||
| 2010 Q2 | 1,213,387 | 0.13 | Buy | 0.13 | $10.65 | $12,923,000 | SEC |
| 2010 Q1 | 0 | 0.00 | Sell 100.00% | 0.16 | SEC | ||
| 2009 Q4 | 1,213,387 | 0.16 | $10.53 | $12,777,000 | SEC | ||
| 2009 Q3 | 1,213,387 | 0.13 | Add 4.04% | <0.01 | $8.25 | $10,010,000 | SEC |
| 2009 Q2 | 1,166,267 | 0.15 | Add 4.18% | <0.01 | $7.87 | $9,179,000 | SEC |
| 2009 Q1 | 1,119,443 | 0.13 | $6.07 | $6,795,000 | SEC | ||
| 2008 Q4 | 1,119,443 | 0.12 | Add 8.96% | <0.01 | $5.83 | $6,526,000 | SEC |
| 2008 Q3 | 1,027,393 | 0.11 | Add 19.17% | 0.02 | $7.38 | $7,582,000 | SEC |
| 2008 Q2 | 862,095 | 0.07 | $7.12 | $6,138,000 | SEC | ||
| 2008 Q1 | 862,095 | 0.10 | Add 32.86% | 0.02 | $9.21 | $7,940,000 | SEC |
| 2007 Q4 | 648,890 | 0.07 | Add 39.31% | 0.02 | $9.53 | $6,184,000 | SEC |
| 2007 Q3 | 465,800 | 0.05 | $8.81 | $4,104,000 | SEC | ||
| 2007 Q2 | 465,800 | 0.04 | $7.85 | $3,657,000 | SEC | ||
| 2007 Q1 | 465,800 | 0.04 | Buy | 0.04 | $8.15 | $3,796,000 | SEC |